Protective effect of a recombinant vaccine against hepatitis B following three immunization schema
DOI:
https://doi.org/10.15381/anales.v67i1.1260Keywords:
Hepatitis B, hepatitis B vaccines, vaccines, syntheticAbstract
Objective: To demonstrate that the protective effect against hepatitis B in susceptible health sciences students is similarly achieved following completion of three vaccination schema, one conventional and two shortened in time and doses. Design: Analytical, experimental, longitudinal, prospective, and concurrent cohorts study. Materials and Methods: The study was performed in 89 last year (internship) Medical Technology students of both sexes and less than 30 year-old, from the Professional Academy School, Faculty of Medicine, San Marcos University. They were distributed in three vaccine receptors groups: one conventional at 0, 1, and 6 months, and two shortened to 0 and 1 month or 0, 1 and 2 months. We excluded those students vaccined against hepatitis B and those positive to surface antigen markers (HBsAg) or total anti core (anti-HBc IgG). According to the cronograme established, we administered the hepatitis B virus recombinant vaccine (REVACB) at 20 mcg/mL concentrations and blood samples were obtained for antibody levels. Results: Average students age was 23,5 yearold, 51,7% (46) were male and 48,3% (43) female. At 30 days from the first dose, 12,4% showed protection; at 30 days post second dose, 98,8%, and at 180 days, 100% obtained protection. Conclusions: Protective effect against hepatitis B was obtained by three different vaccination schema: conventional (three doses), shortened (two doses), and shortened (three doses). We propose the possibility of administering the two doses plan with less cost and same benefit.Downloads
Published
2006-03-13
Issue
Section
Trabajos originales
License
Copyright (c) 2006 Luis Marocho, Herman Vildózola, Esther Valencia, Giuliana Romero, Ana Huamán, Luis Solano, Jorge Chumpitaz, Juan Medina, Elizabeth Pareja
![Creative Commons License](http://i.creativecommons.org/l/by-nc-sa/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Those authors who have publications with this magazine accept the following terms:
- Authors will retain their copyrights and guarantee the journal the right of first publication of their work, which will be simultaneously subject to Creative Commons Attribution License that allows third parties to share the work as long as its author and its first publication this magazine are indicated.
- Authors may adopt other non-exclusive licensing agreements for the distribution of the version of the published work (eg, deposit it in an institutional electronic file or publish it in a monographic volume) provided that the initial publication in this magazine is indicated.
- Authors are allowed and recommended to disseminate their work over the Internet (eg: in institutional telematic archives or on their website) before and during the submission process, which It can produce interesting exchanges and increase quotes from the published work. (See El efecto del acceso abierto ).
How to Cite
1.
Marocho L, Vildózola H, Valencia E, Romero G, Huamán A, Solano L, et al. Protective effect of a recombinant vaccine against hepatitis B following three immunization schema. An Fac med [Internet]. 2006 Mar. 13 [cited 2024 Aug. 16];67(1):5-10. Available from: https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/1260